8.90
-0.28 (-3.00%)
| Previous Close | 9.17 |
| Volume | 159,508 |
| Price / Sales | 6.02 |
| Price / Book | 10.76 |
| 52 Weeks Range |
| Profit Margin | -64.51% |
| Operating Margin (TTM) | -72.63% |
| Diluted EPS (TTM) | -0.760 |
| Quarterly Revenue Growth (YOY) | 11.10% |
| Total Debt/Equity (MRQ) | 17.20% |
| Current Ratio (MRQ) | 3.53 |
| Operating Cash Flow (TTM) | -11.28 M |
| Levered Free Cash Flow (TTM) | -2.92 M |
| Return on Assets (TTM) | -32.39% |
| Return on Equity (TTM) | -76.21% |
AIStockmoo Score
| Value 38% | 0.0 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | 0.0 |
| Timing 38% | -2.1 |
| AI Technical info | NA |
| Technical Oscillators info | -2.5 |
| Technical Moving Averages info | -1.5 |
| Sentiment 25% | 0.0 |
| Analyst Consensus info | 0.0 |
| News Mood info | NA |
| Smart Money | NA |
| Insider Activity info | NA |
| Institutional Flow info | NA |
| Short Interest info | NA |
| Environment | ×1.16 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | -5.7% |
| Pillar Agreement | ×1.00 |
| Not in score | |
| Price Volatility info | 2.3 |
| Final Score | -0.92 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | ClearPoint Neuro Inc. | Mixed | Bearish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| CLPT | - | - | - | 10.76 |
| ZIMV | 535 M | - | - | 1.29 |
| ARAY | - | - | - | 0.170 |
| KIDS | - | - | - | 2.61 |
| NPCE | - | - | - | 38.49 |
| BRKR | - | 0.32% | - | 4.10 |
Select this tab to load the latest available analysis.
|
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 8.22% |
| % Held by Institutions | 34.64% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |